FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. BABA
9. NTES
10. DE

Go back to FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
(NASDAQ: VELO) Delayed: 13.30 +0.13 (0.99%)
Previous Close $13.17    52 Week High $ 
Open $13.38    52 Week Low $ 
Day High $13.75    P/E N/A 
Day Low $12.71    EPS $ 
Volume 878,567